+102.1%
GSK vs SBAC
+92.8%
+9.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -0.7% | -0.7% | -1.2% |
| 7D | -3.1% | -8.1% | +5.0% | -1.1% |
| 30D | -0.9% | -4.7% | +3.8% | +0.2% |
| 3M | -4.2% | -3.1% | -1.1% | -3.6% |
| 6M | -1.6% | -13.0% | +11.4% | +1.3% |
| YTD | +2.6% | -8.0% | +10.6% | +3.4% |
| 1Y | +6.2% | -9.9% | +16.2% | +7.7% |
| 3Y | +55.0% | -20.8% | +75.8% | +60.6% |
| 5Y | +42.8% | -45.1% | +87.9% | +60.1% |
| 10Y | +102.1% | +91.3% | +10.8% | +80.2% |
| All | +102.1% | +92.8% | +9.4% | +80.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling